Formation of a 16,17-trans-glycolic metabolite from a 16-dehydro-androgen in human fetal liver microsomes

Anders Rane, Jan-Ake Gustafsson

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

This study aimed to investigate if the human fetus can form epoxides during the oxidation of double bonds. Indirect evidence for this was obtained using 4,16-androstadien-3-one as substrate o f the liver microsomal drug oxidation enzyme system. Human fetal liver microsomes were shown to catalyze the formation of the corresponding 16,17-glycol, a reaction that is thought to proceed via an intermediary 16,17-epoxide. The findings may imply that the human fetus is also capable of forming epoxides from certain drugs that contain double bonds.

Original languageEnglish (US)
Pages (from-to)833-839
Number of pages7
JournalClinical Pharmacology and Therapeutics
Volume14
Issue number5
DOIs
StatePublished - Jan 1 1973

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Formation of a 16,17-trans-glycolic metabolite from a 16-dehydro-androgen in human fetal liver microsomes'. Together they form a unique fingerprint.

Cite this